Uncategorized
November 16, 2019 – FDA Approves Talicia To Treat Superbug Linked To Stomach Cancer
Health officials are increasingly concerned about the rise of antibiotic-resistant infections, also known as ‘superbugs’. However, this month an Israel-based pharmaceutical company showed that we may be able to combat this threat. View Full Article
Read MoreNovember 12, 2019 – FDA Grants Breakthrough Status to AI-Based Gastric Cancer Diagnostic
The FDA granted breakthrough device designation to AI Medical Service’s technology for diagnosing gastric cancer, the company said Monday. The technology uses artificial intelligence to analyze endoscopy images for signs of gastric cancer, a hard-to-diagnose disease associated with a high rate of false negatives. AI Medical Service, which raised $42.9 million last month, is working to bring…
Read MoreJuly 4, 2019 – Study Uncovers Origin of Cell Layer that Hides Stomach Cancer
A group of researchers from Hiroshima recently discovered the origin of a normal-looking stomach lining that covers sites of gastric cancer and makes it difficult to spot after the eradication of an H. pylori infection. H. pylori infection is a major cause of stomach cancer and causes inflammation by releasing substances that can destroy cells…
Read MoreJuly 2, 2019 – Greater Awareness Needed of Stomach Cancer Risk in Under-40s, Especially in Latin America [ESMO World GI Press Release]
Stomach cancer should no longer be considered a disease only of older people, and patients under 40 with chronic digestive symptoms should be more actively investigated – especially if they are of Latin American ethnicity. This advice follows new data from a retrospective, observational study in Mexico which showed that one in seven of over…
Read More